Literature DB >> 26541745

Hyaluronan as a therapeutic target in human diseases.

Jiurong Liang1, Dianhua Jiang1, Paul W Noble2.   

Abstract

Accumulation and turnover of extracellular matrix is a hallmark of tissue injury, repair and remodeling in human diseases. Hyaluronan is a major component of the extracellular matrix and plays an important role in regulating tissue injury and repair, and controlling disease outcomes. The function of hyaluronan depends on its size, location, and interactions with binding partners. While fragmented hyaluronan stimulates the expression of an array of genes by a variety of cell types regulating inflammatory responses and tissue repair, cell surface hyaluronan provides protection against tissue damage from the environment and promotes regeneration and repair. The interactions of hyaluronan and its binding proteins participate in the pathogenesis of many human diseases. Thus, targeting hyaluronan and its interactions with cells and proteins may provide new approaches to developing therapeutics for inflammatory and fibrosing diseases. This review focuses on the role of hyaluronan in biological and pathological processes, and as a potential therapeutic target in human diseases.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  4-Methylumbelliferone (PubChem CID: 5280567); Extracellular matrix; Glycyrrhizin (PubChem CID: 3495); Hyaluronic acid (PubChem CID: 453618); Sodium hyaluronate (PubChem CID: 3084049); hyaluronan

Mesh:

Substances:

Year:  2015        PMID: 26541745      PMCID: PMC4753080          DOI: 10.1016/j.addr.2015.10.017

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  335 in total

1.  Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I.C).

Authors:  C A de La Motte; V C Hascall; A Calabro; B Yen-Lieberman; S A Strong
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

Review 2.  Hyaluronan: from extracellular glue to pericellular cue.

Authors:  Bryan P Toole
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

3.  CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity.

Authors:  R Schmits; J Filmus; N Gerwin; G Senaldi; F Kiefer; T Kundig; A Wakeham; A Shahinian; C Catzavelos; J Rak; C Furlonger; A Zakarian; J J Simard; P S Ohashi; C J Paige; J C Gutierrez-Ramos; T W Mak
Journal:  Blood       Date:  1997-09-15       Impact factor: 22.113

4.  Hyaluronan Controls the Deposition of Fibronectin and Collagen and Modulates TGF-β1 Induction of Lung Myofibroblasts.

Authors:  Stephen P Evanko; Susan Potter-Perigo; Loreen J Petty; Gail A Workman; Thomas N Wight
Journal:  Matrix Biol       Date:  2014-12-27       Impact factor: 11.583

5.  Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines.

Authors:  Carol de la Motte; Julie Nigro; Amit Vasanji; Hyunjin Rho; Sean Kessler; Sudip Bandyopadhyay; Silvio Danese; Claudio Fiocchi; Robert Stern
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

6.  Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate.

Authors:  Shuang Cai; Yumei Xie; Taryn R Bagby; Mark S Cohen; M Laird Forrest
Journal:  J Surg Res       Date:  2008-03-26       Impact factor: 2.192

7.  Activation of eosinophils and fibroblasts assessed by eosinophil cationic protein and hyaluronan in BAL. Association with acute rejection in lung transplant recipients.

Authors:  G C Riise; H Scherstén; F Nilsson; W Ryd; B A Andersson
Journal:  Chest       Date:  1996-07       Impact factor: 9.410

8.  KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization.

Authors:  Hiroyuki Yoshida; Aya Nagaoka; Ayumi Kusaka-Kikushima; Megumi Tobiishi; Keigo Kawabata; Tetsuya Sayo; Shingo Sakai; Yoshinori Sugiyama; Hiroyuki Enomoto; Yasunori Okada; Shintaro Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

9.  TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exerts a strong anti-inflammatory effect in vivo.

Authors:  H G Wisniewski; J C Hua; D M Poppers; D Naime; J Vilcek; B N Cronstein
Journal:  J Immunol       Date:  1996-02-15       Impact factor: 5.422

Review 10.  CD44 Acts as a Signaling Platform Controlling Tumor Progression and Metastasis.

Authors:  Véronique Orian-Rousseau
Journal:  Front Immunol       Date:  2015-04-08       Impact factor: 7.561

View more
  52 in total

1.  Levels of low-molecular-weight hyaluronan in periodontitis-treated patients and its immunostimulatory effects on CD4+ T lymphocytes.

Authors:  Francisca Castillo; Gustavo Monasterio; Juan Pablo Ibarra; José Guevara; Emilio A Cafferata; Emiliano Vicencio; Cristian Cortez; Paola Carvajal; Rolando Vernal
Journal:  Clin Oral Investig       Date:  2021-02-05       Impact factor: 3.573

2.  Increased Hyaluronan and TSG-6 in Association with Neuropathologic Changes of Alzheimer's Disease.

Authors:  May J Reed; Mamatha Damodarasamy; Jasmine L Pathan; Christina K Chan; Charles Spiekerman; Thomas N Wight; William A Banks; Anthony J Day; Robert B Vernon; C Dirk Keene
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

3.  Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.

Authors:  Yoon Mee Yang; Zhijun Wang; Michitaka Matsuda; Ekihiro Seki
Journal:  Arch Pharm Res       Date:  2021-01-24       Impact factor: 4.946

4.  Extracellular Matrix Receptor Expression in Subtypes of Lung Adenocarcinoma Potentiates Outgrowth of Micrometastases.

Authors:  Laura E Stevens; William K C Cheung; Sally J Adua; Anna Arnal-Estapé; Minghui Zhao; Zongzhi Liu; Kelly Brewer; Roy S Herbst; Don X Nguyen
Journal:  Cancer Res       Date:  2017-02-14       Impact factor: 12.701

Review 5.  Hyaluronan in the experimental injury of the cartilage: biochemical action and protective effects.

Authors:  Angela Avenoso; Angela D'Ascola; Michele Scuruchi; Giuseppe Mandraffino; Alberto Calatroni; Antonino Saitta; Salvatore Campo; Giuseppe M Campo
Journal:  Inflamm Res       Date:  2017-08-12       Impact factor: 4.575

6.  Mitogen-activated Protein Kinase-activated Protein Kinase 2 Inhibition Attenuates Fibroblast Invasion and Severe Lung Fibrosis.

Authors:  Jiurong Liang; Ningshan Liu; Xue Liu; Jessica Monterrosa Mena; Ting Xie; Yan Geng; Caijuan Huan; Yanli Zhang; Forough Taghavifar; Guanling Huang; Adrianne Kurkciyan; Vivian Barron; Dianhua Jiang; Paul W Noble
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

7.  Cardiac mesenchymal cells from failing and nonfailing hearts limit ventricular dilation when administered late after infarction.

Authors:  Timothy N Audam; Yibing Nong; Alex Tomlin; Andrea Jurkovic; Hong Li; Xiaoping Zhu; Bethany W Long; Yi Wei Zheng; Tyler Weirick; Kenneth R Brittian; Daniel W Riggs; Anna Gumpert; Shizuka Uchida; Yiru Guo; Marcin Wysoczynski; Steven P Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-22       Impact factor: 4.733

8.  Bioactive hyaluronic acid fragments inhibit lipopolysaccharide-induced inflammatory responses via the Toll-like receptor 4 signaling pathway.

Authors:  Na You; Sasa Chu; Binggang Cai; Youfang Gao; Mizhou Hui; Jin Zhu; Maorong Wang
Journal:  Front Med       Date:  2020-09-18       Impact factor: 4.592

9.  Therapeutic Effects of Hyaluronic Acid in Bacterial Pneumonia in Ex Vivo Perfused Human Lungs.

Authors:  Airan Liu; Jeong-Hyun Park; Xiwen Zhang; Shinji Sugita; Yoshifumi Naito; Jae-Hoon Lee; Hideya Kato; Qi Hao; Michael A Matthay; Jae-Woo Lee
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

10.  Low-molecular-mass hyaluronan induces pulmonary inflammation by up-regulation of Mcl-1 to inhibit neutrophil apoptosis via PI3K/Akt1 pathway.

Authors:  Hang Zhao; Yating Ma; Leifang Zhang
Journal:  Immunology       Date:  2018-07-26       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.